0000950123-21-002304.txt : 20210216 0000950123-21-002304.hdr.sgml : 20210216 20210216065431 ACCESSION NUMBER: 0000950123-21-002304 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRV GP II, LLC CENTRAL INDEX KEY: 0001614073 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18419 FILM NUMBER: 21632251 BUSINESS ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001614073 XXXXXXXX 12-31-2020 12-31-2020 false TRV GP II, LLC
Third Rock Ventures 29 Newbury Street, 3rd Floor Boston MA 02116
13F HOLDINGS REPORT 028-18419 N
Kevin Gillis Chief Operating Officer 617-585-2000 /s/ Kevin Gillis Boston MA 02-16-2021 3 3 143564 false 1 028-18439 Mark Levin 2 028-18438 Kevin P. Starr 3 028-18419 Robert I. Tepper
INFORMATION TABLE 2 3349.xml INFORMATION TABLE FOR FORM 13F JOUNCE THERAPEUTICS, INC. COM 481116101 64402 9200349 SH DFND 1,2,3 9200349 0 0 ALLENA PHARMACEUTICALS, INC. COM 018119107 3572 2790964 SH DFND 1,2,3 2790964 0 0 REVOLUTION MEDICINES, INC. COM 76155X100 75590 1909317 SH DFND 1,2,3 1909317 0 0